Skip to main content

Werewolf Therapeutics, Inc.

HOWL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001785530

In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Werewolf Therapeutics, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of HOWL: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders62351−8
Shares21.1M4.37M14.7M−2.00M (−12.0%)
Value$41.6M$8.61M$9.34M−$23.6M (−71.7%)

3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held Werewolf Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to HOWL in Q4 2025
InstitutionSharesValue% of portfolio
Lynx1 Capital Management LP655,926$415.5K0.08%
Delta Investment Management, LLC14,925$9.46K0.00%
Point72 Asset Management, L.P.14,483$9.18K0.00%
Engineers Gate Manager LP12,185$7.72K0.00%
Pacitti Group Inc.12,000$7.60K0.00%
StoneX Group Inc.10,511$6.66K0.00%
Northwestern Mutual Wealth Management Co4$30.00%

Sold out (15)

Institutions that held Werewolf Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Not filed for Q4 2025 yet (3)

Institutions that held Werewolf Therapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HOWL in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
MPM Asset Management LLC4,309,860$8.49M
Cubist Systematic Strategies, LLC46,711$92.0K
Point72 Asia (Singapore) Pte. Ltd.13,016$25.6K